ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,420,014, issued on Sept. 23, was assigned to CLOSED LOOP MEDICINE LTD. (Cambridge, Great Britain).
"Dosing of incretin pathway drugs" was invented by Paul Goldsmith (London), David Bruce Campbell (London), Michael Catt (Wellingborough, Great Britain), Tom Godec (London) and Joe Coghlin (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method for administering a dosage of Cagrisema to a patient for the treatment of obesity, the method comprising: administering a dosage of Cagrisema to the patient, wherein the dosage of Cagrisema is determined by: receiving patient data relating to a patient, wherein the patient data includes patient weight data; ...